Differentiating Parkinson's disease from other parkinsonian disorders

被引：7
|
作者：
Alvarez, Maria V. [1 ]
Evidente, Virgilio Gerald H. [1 ]
Driver-Dunckley, Erika D. [1 ]
机构：
[1] Mayo Clin, Dept Neurol, Parkinsons Dis & Movement Disorders Ctr, Scottsdale, AZ 85259 USA
来源：
SEMINARS IN NEUROLOGY | 2007年 / 27卷 / 04期
关键词：
parkinsonism; parkinsonian plus; atypical parkinsonism; tardive movements; drug-induced parkinsonism;
D O I：
10.1055/s-2007-985336
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In 1817, James Parkinson formally described the shaking palsy that is now known as idiopathic Parkinson's disease (PD). Symptoms of PD, however, existed for thousands of years before that time. Descriptions evolved significantly until the term parkinsonism was eventually coined to describe neurologic disorders characterized by the presence of tremor, rigidity, and bradykinesia in addition to loss of postural reflexes and freezing. In this article, we present some useful clinical pearls in distinguishing idiopathic PD from atypical parkinsonism or drug-induced parkinsonism.
引用
收藏
页码：356 / 362
页数：7
相关论文
共 50 条
  • [41] Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging
    Savoiardo, M
    NEUROLOGICAL SCIENCES, 2003, 24 (Suppl 1) : S35 - S37
  • [42] Serum and cerebrospinal fluid urate levels in Parkinson's disease and atypical parkinsonian disorders
    Constantinescu, R.
    Andreasson, U.
    Holmberg, B.
    Zetterberg, H.
    MOVEMENT DISORDERS, 2010, 25 (07) : S496 - S496
  • [43] Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders
    Hall, Sara
    Janelidze, Shorena
    Surova, Yulia
    Widner, Hakan
    Zetterberg, Henrik
    Hansson, Oskar
    SCIENTIFIC REPORTS, 2018, 8
  • [44] Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
    Sara Hall
    Shorena Janelidze
    Yulia Surova
    Håkan Widner
    Henrik Zetterberg
    Oskar Hansson
    Scientific Reports, 8
  • [45] Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging
    M. Savoiardo
    Neurological Sciences, 2003, 24 : s35 - s37
  • [46] Importance of myocardial MIBG scintigraphy in differentiating idiopatic Parkinson's disease from other neurodegenerative diseases
    Petrovic, R.
    Golubic, A. T.
    Samardzic, T.
    Klepac, N.
    Telarovic, S.
    Tezak, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S569 - S570
  • [47] Daytime sleepiness and other sleep disorders in Parkinson's disease
    Homann, CN
    Forstner, M
    Ivanic, G
    Ott, E
    NEUROLOGY, 2002, 58 (12) : 1863 - 1863
  • [48] Other Proteins Involved in Parkinson's Disease and Related Disorders
    Cardona, Fernando
    Perez-Tur, Jordi
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (07) : 765 - 778
  • [49] Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
    Krüger, R
    Müller, T
    Riess, O
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (01) : 31 - 40
  • [50] Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
    R. Krüger
    T. Müller
    O. Riess
    Journal of Neural Transmission, 2000, 107 : 31 - 40
12345